John Canavan stated that reference to the HCV screening being marginal in terms of cost benefit by the Department of Health related to the economic cost-benefit and not the public health benefit.
Linked evidence
Chronology Information
Date:
Chapter/issue
Hepatitis C Screening
Key Person(s)
John Canavan